Fingolimod
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Fingolimod Product Information
Fingolimod is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Fingolimod. The product is supplied by Clearsynth under CAT No. CS-O-01552.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Fingolimod
CAS No.
162359-55-9
CAT No.
CS-O-01552
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C19H33NO2
Molecular Weight
307.47
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Fingolimod is supplied with detailed characterization data compliant with regulatory guideline. Fingolimod can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Fingolimod.
Overview
Fingolimod is a sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS??
Synonyms
Fingolimod
Application Notes
Fingolimod is a sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS??
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.